K-numberK243309
Device name27G x 1/2 TW K-Pack Surshield Needle (KN-S2713RBT)
ApplicantTerumo Europe N.V.
Product codeFMI
Device classClass II
Decision dateMay 29, 2025
DecisionSubstantially Equivalent
Regulation880.5570
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The 27G x 1/2" TW K-Pack Surshield Needle is a hypodermic needle with a passive sharps protection feature that automatically covers the needle immediately and permanently after use. It is designed for subcutaneous and intramuscular injection in combination with pre-filled syringes, and includes a female luer connector hub made of polypropylene to attach to syringe nozzles.

Technological characteristics

The subject device has a thin-wall (TW) cannula with an increased inner diameter (0.241–0.281 mm) compared to the predicate's regular wall (0.20–0.24 mm inner diameter), while maintaining the same 27G (0.4 mm) outer diameter, 1/2" length, regular bevel, stainless steel tube, polypropylene hub, and passive sharps protection mechanism. All materials, design construction, sterilization method (ethylene oxide to SAL 10⁻⁶), packaging, and 5-year shelf life remain identical.

Test standards cited

ISO 7864:2016 (sterile hypodermic needles), ISO 9626:2016 (stainless steel needle tubing), ISO 80369-7:2021 (small bore connectors), ISO 23908:2011 (sharps injury protection), ISO 11607-1:2019 (packaging for sterilized devices), EN ISO 11135:2014 (ethylene oxide sterilization), ISO 10993-1:2020 (biocompatibility), ISO 10993-7 (EO residual limits), USP <788> (particulate matter), USP <71> (sterility), and USP <85>/<161> (bacterial endotoxin limits).

Substantial equivalence argument

The increased inner diameter of the thin-wall cannula is a design optimization that does not raise new safety or effectiveness questions because both devices share identical indications for use, intended use, materials, sharps protection mechanism, sterilization validation, and biocompatibility profile. Performance verification testing under ISO 7864 and ISO 9626 demonstrates the thin-wall version performs equivalently to the predicate's regular-wall design, and no clinical data are required because the device is a manual hypodermic needle without novel active elements or patient contact differences.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →